Filho et al. Retrospective Brazilian study. ADA vs LEF in Takayasu arteritis. Comparable renission, relapses, steroid dose, ESR, CRP, imaging over median 15 weeks. More AEs in LEF but non-severe. @RheumNow #ACR22 Abstr#1553 https://t.co/499dUNmpUD https://t.co/AEk5cG7dc4
Links:
Effectiveness and Safety of Adalimumab versus Leflunomide in Patients with Taka…
https://acrabstracts.org/abstract/effectiveness-and-safety-of-adalimumab-versus…
13-11-2022